The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-hydroxybenzenesulfonamide
ID: ALA4799668
PubChem CID: 162676836
Max Phase: Preclinical
Molecular Formula: C13H11F3N2O3S
Molecular Weight: 332.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(NS(=O)(=O)c2ccc(O)cc2)cc1C(F)(F)F
Standard InChI: InChI=1S/C13H11F3N2O3S/c14-13(15,16)11-7-8(1-6-12(11)17)18-22(20,21)10-4-2-9(19)3-5-10/h1-7,18-19H,17H2
Standard InChI Key: DZTLAGGCPZDEOE-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
5.0228 -14.7590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6184 -14.0532 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.2094 -14.7564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0367 -14.0532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0356 -14.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7436 -15.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4533 -14.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4504 -14.0496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7418 -13.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3289 -13.6447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9135 -13.6451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9169 -12.8273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2100 -12.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5014 -12.8278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5042 -13.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2117 -14.0538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1616 -15.2797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7434 -16.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0356 -16.5073 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.4510 -16.5076 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.7356 -16.9134 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.7930 -12.4203 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.30 | Molecular Weight (Monoisotopic): 332.0442 | AlogP: 2.79 | #Rotatable Bonds: 3 |
Polar Surface Area: 92.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.08 | CX Basic pKa: 2.31 | CX LogP: 2.21 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.75 | Np Likeness Score: -1.28 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |